SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. Lebrun, The radiologically isolated syndrome, Revue Neurologique, 2015, 171, 10, 698

    CrossRef

  2. 2
    T. Gabelic, D. P. Ramasamy, B. Weinstock-Guttman, J. Hagemeier, C. Kennedy, R. Melia, D. Hojnacki, M. Ramanathan, R. Zivadinov, Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Patients with Multiple Sclerosis, American Journal of Neuroradiology, 2014, 35, 1, 106

    CrossRef

  3. 3
    Giovanni Ristori, Silvia Romano, Stefania Cannoni, Carla Buttinelli, Giulia Coarelli, Nicola Vanacore, Carlo Pozzilli, Marco Salvetti, The Value of BCG and TNF in Autoimmunity, 2014,

    CrossRef

  4. 4
    Aksel Siva, Asymptomatic MS, Clinical Neurology and Neurosurgery, 2013, 115, S1

    CrossRef

  5. 5
    Jimmy L Huynh, Patrizia Casaccia, Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment, The Lancet Neurology, 2013, 12, 2, 195

    CrossRef

  6. 6
    Tereza Gabelic, Bianca Weinstock-Guttman, Rebecca Melia, Norah Lincoff, Muhammad W. Masud, Cheryl Kennedy, Vesna Brinar, Deepa P. Ramasamy, Ellen Carl, Niels Bergsland, Murali Ramanathan, Robert Zivadinov, Retinal nerve fiber thickness and MRI white matter abnormalities in healthy relatives of multiple sclerosis patients, Clinical Neurology and Neurosurgery, 2013, 115, S49

    CrossRef

  7. 7
    S. Vukusic, Prévenir la sclérose en plaques : un objectif réaliste ?, Revue Neurologique, 2012, 168, 11, 836

    CrossRef

  8. 8
    D. Brassat, When does multiple sclerosis start? Three case reports and a review of the literature, Revue Neurologique, 2012, 168, 11, 846

    CrossRef

  9. You have free access to this content9
    M. Filippi, F. Agosta, Imaging biomarkers in multiple sclerosis, Journal of Magnetic Resonance Imaging, 2010, 31, 4
  10. 10
    Sreeram V Ramagopalan, Ruth Dobson, Ute C Meier, Gavin Giovannoni, Multiple sclerosis: risk factors, prodromes, and potential causal pathways, The Lancet Neurology, 2010, 9, 7, 727

    CrossRef

  11. 11
    Paul M. Matthews, Brain Imaging of Multiple Sclerosis: the Next 10 Years, Neuroimaging Clinics of North America, 2009, 19, 1, 101

    CrossRef

  12. 12
    Darin T. Okuda, Unanticipated demyelinating pathology of the CNS, Nature Reviews Neurology, 2009, 5, 11, 591

    CrossRef

  13. 13
    B. Hakiki, B. Goretti, E. Portaccio, V. Zipoli, M. P. Amato, ‘Subclinical MS’: follow-up of four cases, European Journal of Neurology, 2008, 15, 8
  14. 14
    Aksel Siva, Immunotherapy for clinically isolated syndrome? Not necessarily..., Nature Clinical Practice Neurology, 2008, 4, 5, 236

    CrossRef

  15. 15
    Ari Green, Emmanuelle Waubant, GENETICS AND EPIDEMIOLOGY OF MULTIPLE SCLEROSIS, CONTINUUM: Lifelong Learning in Neurology, 2007, 13, 63

    CrossRef

  16. 16
    Nicola De Stefano, Marco Battaglini, Stephen M. Smith, Measuring Brain Atrophy in Multiple Sclerosis, Journal of Neuroimaging, 2007, 17,
  17. 17
    Robert N. S. Heard, The spectrum of multiple sclerosis, Current Allergy and Asthma Reports, 2007, 7, 4, 280

    CrossRef

  18. You have free access to this content18
    Stephen L. Hauser, Multiple sclerosis: Tip of the iceberg?, Annals of Neurology, 2006, 59, 4